Stay updated on Nivolumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:52:54.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:38:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations in China and Russia, as well as a new economic evaluation study related to lung cancer treatment. Additionally, there has been a revision update from v2.16.12 to v3.0.0.
    Difference
    7%
    Check dated 2025-08-31T11:30:40.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:38:01.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T23:58:24.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T18:20:25.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in NSCLC: Clinical Trial page.